Q Guidance System with Spine Guidance 5 Software featuring Copilot is a first-to-market technology, pioneering new planning and surgical capabilities

LEESBURG, Va. , July 30, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, today announced that its Q Guidance System with Spine Guidance 5 Software featuring Copilot received 510(k) clearance from the U.S. Food and Drug Administration. This first-to-market technology seamlessly integrates smart-powered* instruments into Stryker's growing ecosystem.

Q Guidance System with Spine Guidance 5 Software featuring Copilot is a first-to-market technology, pioneering new planning and surgical capabilities.

Spine Guidance Software with Copilot's breakthrough ­technology was built to provide multiple feedback modalities for supporting bone resection, pedicle preparation and screw delivery to help maximize a surgeon's effectiveness and enhance patient outcomes. Stryker engaged over 850 orthopaedic spine surgeons and neurosurgeons to develop this technology.

"This project is a prime example of our mission in action," said Dylan Crotty, president of Stryker's Instruments division. "We listened to our customers' evolving needs and are engaging leading surgeons to create a product that adds confidence to their workflow."  

Smart Zones for bone resection provide auditory and sensory feedback when surgeons approach the planned boundaries of anatomical alert zones with the high-speed drill. To complement Smart Zones, the Copilot Smart Driver** stops automatically when it reaches the planned depth, supporting surgeon precision during pedicle preparation and screw placement. The automatic depth stop feature is proprietary technology that unlocks only when using a Stryker implant.

"Spine Guidance Software with Copilot is just the beginning of our development pipeline," said Robbie Robinson, president of Stryker's Spine division. "While focusing on innovation and the integration of our implants, instrumentation and enabling technologies, we strive to help surgeons perform safe and efficient procedures that enable better patient outcomes."

The first clinical cases using Spine Guidance Software with Copilot will begin in September, with a full commercial launch expected later this fall. For more information on Spine Guidance Software with Copilot please visit https://www.stryker.com/us/en/nse/products/spine-guidance-software-copilot.html.

*Smart features enabled by the Q Guidance System with Spine Guidance 5 Software.
**SPINE-COP-BROC-1169302

About Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.  

Media contact
Sarah Yerden
509 438 1198
sarah.yerden@stryker.com

Stryker Logo. (PRNewsFoto/Stryker)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/strykers-spine-guidance-5-software-featuring-copilot-receives-510k-clearance-from-fda-302209090.html

SOURCE Stryker

Copyright 2024 PR Newswire

Stryker (NYSE:SYK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Stryker Charts.
Stryker (NYSE:SYK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Stryker Charts.